Systemic Therapy for TNBC in Neoadjuvant Setting: Initial Treatment for Stage II/III, Chemo as a Potential SoC and Preferred Treatment Strategy, Checkpoint Inhibitors Under Clinical Investigation
By
Xth Eurasian Hematology-Oncology Congress
FEATURING
Ozlem Er
By
Xth Eurasian Hematology-Oncology Congress
FEATURING
Ozlem Er
Login to view comments.
Click here to Login
